APO Research, Inc.

APO RESEARCH · REPORT

Angiotensin II Receptor

Selected research

Market Analysis & Forecast

Global Angiotensin II Receptor Market Analysis and Forecast 2026-2032

Market perspective

The global Angiotensin II Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Angiotensin II Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Angiotensin II Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Angiotensin II Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Angiotensin II Receptor is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Angiotensin II Receptor include CJ HealthCare Corp, MorphoSys AG, Vicore Pharma AB and Novartis AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Angiotensin II Receptor, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Angiotensin II Receptor, also provides the sales of main regions and countries. Of the upcoming market potential for Angiotensin II Receptor, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Angiotensin II Receptor sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Angiotensin II Receptor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Angiotensin II Receptor sales, projected growth trends, production technology, application and end-user industry.

Angiotensin II Receptor Segment by Company

CJ HealthCare Corp

MorphoSys AG

Vicore Pharma AB

Novartis AG

Angiotensin II Receptor Segment by Type

MOR-107

KDT-501

EMA-401

C-21

Others

Angiotensin II Receptor Segment by Application

Women's Health

Immunology

Acute Ischemic Stroke

Respiratory

Others

Angiotensin II Receptor Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Angiotensin II Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Angiotensin II Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Angiotensin II Receptor.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Angiotensin II Receptor in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Angiotensin II Receptor manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Angiotensin II Receptor sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Angiotensin II Receptor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. MOR-107 Major Manufacturers Table 3. KDT-501 Major Manufacturers Table 4. EMA-401 Major Manufacturers Table 5. C-21 Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Angiotensin II Receptor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Women's Health Major Manufacturers Table 9. Immunology Major Manufacturers Table 10. Acute Ischemic Stroke Major Manufacturers Table 11. Respiratory Major Manufacturers Table 12. Others Major Manufacturers Table 13. Angiotensin II Receptor Industry Trends Table 14. Angiotensin II Receptor Industry Drivers Table 15. Angiotensin II Receptor Industry Opportunities and Challenges Table 16. Angiotensin II Receptor Industry Restraints Table 17. Global Angiotensin II Receptor Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Angiotensin II Receptor Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Angiotensin II Receptor Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Angiotensin II Receptor Revenue Market Share by Region (2021-2026) Table 21. Global Angiotensin II Receptor Revenue Market Share by Region (2027-2032) Table 22. Global Angiotensin II Receptor Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 23. Global Angiotensin II Receptor Sales by Region (2021-2026) & (k units) Table 24. Global Angiotensin II Receptor Sales by Region (2027-2032) & (k units) Table 25. Global Angiotensin II Receptor Sales Market Share by Region (2021-2026) Table 26. Global Angiotensin II Receptor Sales Market Share by Region (2027-2032) Table 27. Global Angiotensin II Receptor Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Angiotensin II Receptor Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Angiotensin II Receptor Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Angiotensin II Receptor Sales Market Share by Manufacturers (2021-2026) Table 31. Global Angiotensin II Receptor Sales Price (US$/unit) of Manufacturers (2021-2026) Table 32. Global Angiotensin II Receptor Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Angiotensin II Receptor Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Angiotensin II Receptor Manufacturers, Product Type & Application Table 35. Global Angiotensin II Receptor Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Angiotensin II Receptor by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Angiotensin II Receptor Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Angiotensin II Receptor Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Angiotensin II Receptor Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Angiotensin II Receptor Revenue Market Share by Type (2021-2026) Table 42. Global Angiotensin II Receptor Revenue Market Share by Type (2027-2032) Table 43. Global Angiotensin II Receptor Sales by Type 2021 VS 2025 VS 2032 (k units) Table 44. Global Angiotensin II Receptor Sales by Type (2021-2026) & (k units) Table 45. Global Angiotensin II Receptor Sales by Type (2027-2032) & (k units) Table 46. Global Angiotensin II Receptor Sales Market Share by Type (2021-2026) Table 47. Global Angiotensin II Receptor Sales Market Share by Type (2027-2032) Table 48. Global Angiotensin II Receptor Price by Type (2021-2026) & (US$/unit) Table 49. Global Angiotensin II Receptor Price by Type (2027-2032) & (US$/unit) Table 50. Global Angiotensin II Receptor Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Angiotensin II Receptor Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Angiotensin II Receptor Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Angiotensin II Receptor Revenue Market Share by Application (2021-2026) Table 54. Global Angiotensin II Receptor Revenue Market Share by Application (2027-2032) Table 55. Global Angiotensin II Receptor Sales by Application 2021 VS 2025 VS 2032 (k units) Table 56. Global Angiotensin II Receptor Sales by Application (2021-2026) & (k units) Table 57. Global Angiotensin II Receptor Sales by Application (2027-2032) & (k units) Table 58. Global Angiotensin II Receptor Sales Market Share by Application (2021-2026) Table 59. Global Angiotensin II Receptor Sales Market Share by Application (2027-2032) Table 60. Global Angiotensin II Receptor Price by Application (2021-2026) & (US$/unit) Table 61. Global Angiotensin II Receptor Price by Application (2027-2032) & (US$/unit) Table 62. CJ HealthCare Corp Company Information Table 63. CJ HealthCare Corp Business Overview Table 64. CJ HealthCare Corp Angiotensin II Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. CJ HealthCare Corp Angiotensin II Receptor Product Portfolio Table 66. CJ HealthCare Corp Recent Development Table 67. MorphoSys AG Company Information Table 68. MorphoSys AG Business Overview Table 69. MorphoSys AG Angiotensin II Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. MorphoSys AG Angiotensin II Receptor Product Portfolio Table 71. MorphoSys AG Recent Development Table 72. Vicore Pharma AB Company Information Table 73. Vicore Pharma AB Business Overview Table 74. Vicore Pharma AB Angiotensin II Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Vicore Pharma AB Angiotensin II Receptor Product Portfolio Table 76. Vicore Pharma AB Recent Development Table 77. Novartis AG Company Information Table 78. Novartis AG Business Overview Table 79. Novartis AG Angiotensin II Receptor Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Novartis AG Angiotensin II Receptor Product Portfolio Table 81. Novartis AG Recent Development Table 82. North America Angiotensin II Receptor Revenue by Type (2021-2026) & (US$ Million) Table 83. North America Angiotensin II Receptor Revenue by Type (2027-2032) & (US$ Million) Table 84. North America Angiotensin II Receptor Sales by Type (2021-2026) & (k units) Table 85. North America Angiotensin II Receptor Sales by Type (2027-2032) & (k units) Table 86. North America Angiotensin II Receptor Sales Price by Type (2021-2026) & (US$/unit) Table 87. North America Angiotensin II Receptor Sales Price by Type (2027-2032) & (US$/unit) Table 88. North America Angiotensin II Receptor Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Angiotensin II Receptor Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Angiotensin II Receptor Sales by Application (2021-2026) & (k units) Table 91. North America Angiotensin II Receptor Sales by Application (2027-2032) & (k units) Table 92. North America Angiotensin II Receptor Sales Price by Application (2021-2026) & (US$/unit) Table 93. North America Angiotensin II Receptor Sales Price by Application (2027-2032) & (US$/unit) Table 94. North America Angiotensin II Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 95. North America Angiotensin II Receptor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 96. North America Angiotensin II Receptor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 97. North America Angiotensin II Receptor Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 98. North America Angiotensin II Receptor Sales by Country (2021-2026) & (k units) Table 99. North America Angiotensin II Receptor Sales by Country (2027-2032) & (k units) Table 100. North America Angiotensin II Receptor Sales Price by Country (2021-2026) & (US$/unit) Table 101. North America Angiotensin II Receptor Sales Price by Country (2027-2032) & (US$/unit) Table 102. United States Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 103. Canada Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 104. Mexico Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 105. Europe Angiotensin II Receptor Revenue by Type (2021-2026) & (US$ Million) Table 106. Europe Angiotensin II Receptor Revenue by Type (2027-2032) & (US$ Million) Table 107. Europe Angiotensin II Receptor Sales by Type (2021-2026) & (k units) Table 108. Europe Angiotensin II Receptor Sales by Type (2027-2032) & (k units) Table 109. Europe Angiotensin II Receptor Sales Price by Type (2021-2026) & (US$/unit) Table 110. Europe Angiotensin II Receptor Sales Price by Type (2027-2032) & (US$/unit) Table 111. Europe Angiotensin II Receptor Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Angiotensin II Receptor Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Angiotensin II Receptor Sales by Application (2021-2026) & (k units) Table 114. Europe Angiotensin II Receptor Sales by Application (2027-2032) & (k units) Table 115. Europe Angiotensin II Receptor Sales Price by Application (2021-2026) & (US$/unit) Table 116. Europe Angiotensin II Receptor Sales Price by Application (2027-2032) & (US$/unit) Table 117. Europe Angiotensin II Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Angiotensin II Receptor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 119. Europe Angiotensin II Receptor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 120. Europe Angiotensin II Receptor Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 121. Europe Angiotensin II Receptor Sales by Country (2021-2026) & (k units) Table 122. Europe Angiotensin II Receptor Sales by Country (2027-2032) & (k units) Table 123. Europe Angiotensin II Receptor Sales Price by Country (2021-2026) & (US$/unit) Table 124. Europe Angiotensin II Receptor Sales Price by Country (2027-2032) & (US$/unit) Table 125. Germany Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 126. France Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 127. U.K. Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 128. Italy Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 129. Russia Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 130. Spain Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 131. Netherlands Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 132. Switzerland Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 133. Sweden Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 134. Poland Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 135. China Angiotensin II Receptor Revenue by Type (2021-2026) & (US$ Million) Table 136. China Angiotensin II Receptor Revenue by Type (2027-2032) & (US$ Million) Table 137. China Angiotensin II Receptor Sales by Type (2021-2026) & (k units) Table 138. China Angiotensin II Receptor Sales by Type (2027-2032) & (k units) Table 139. China Angiotensin II Receptor Sales Price by Type (2021-2026) & (US$/unit) Table 140. China Angiotensin II Receptor Sales Price by Type (2027-2032) & (US$/unit) Table 141. China Angiotensin II Receptor Revenue by Application (2021-2026) & (US$ Million) Table 142. China Angiotensin II Receptor Revenue by Application (2027-2032) & (US$ Million) Table 143. China Angiotensin II Receptor Sales by Application (2021-2026) & (k units) Table 144. China Angiotensin II Receptor Sales by Application (2027-2032) & (k units) Table 145. China Angiotensin II Receptor Sales Price by Application (2021-2026) & (US$/unit) Table 146. China Angiotensin II Receptor Sales Price by Application (2027-2032) & (US$/unit) Table 147. Asia Angiotensin II Receptor Revenue by Type (2021-2026) & (US$ Million) Table 148. Asia Angiotensin II Receptor Revenue by Type (2027-2032) & (US$ Million) Table 149. Asia Angiotensin II Receptor Sales by Type (2021-2026) & (k units) Table 150. Asia Angiotensin II Receptor Sales by Type (2027-2032) & (k units) Table 151. Asia Angiotensin II Receptor Sales Price by Type (2021-2026) & (US$/unit) Table 152. Asia Angiotensin II Receptor Sales Price by Type (2027-2032) & (US$/unit) Table 153. Asia Angiotensin II Receptor Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Angiotensin II Receptor Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Angiotensin II Receptor Sales by Application (2021-2026) & (k units) Table 156. Asia Angiotensin II Receptor Sales by Application (2027-2032) & (k units) Table 157. Asia Angiotensin II Receptor Sales Price by Application (2021-2026) & (US$/unit) Table 158. Asia Angiotensin II Receptor Sales Price by Application (2027-2032) & (US$/unit) Table 159. Asia Angiotensin II Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 160. Asia Angiotensin II Receptor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 161. Asia Angiotensin II Receptor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 162. Asia Angiotensin II Receptor Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 163. Asia Angiotensin II Receptor Sales by Country (2021-2026) & (k units) Table 164. Asia Angiotensin II Receptor Sales by Country (2027-2032) & (k units) Table 165. Asia Angiotensin II Receptor Sales Price by Country (2021-2026) & (US$/unit) Table 166. Asia Angiotensin II Receptor Sales Price by Country (2027-2032) & (US$/unit) Table 167. Japan Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 168. South Korea Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 169. India Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 170. Australia Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 171. Taiwan Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 172. Southeast Asia Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 173. SAMEA Angiotensin II Receptor Revenue by Type (2021-2026) & (US$ Million) Table 174. SAMEA Angiotensin II Receptor Revenue by Type (2027-2032) & (US$ Million) Table 175. SAMEA Angiotensin II Receptor Sales by Type (2021-2026) & (k units) Table 176. SAMEA Angiotensin II Receptor Sales by Type (2027-2032) & (k units) Table 177. SAMEA Angiotensin II Receptor Sales Price by Type (2021-2026) & (US$/unit) Table 178. SAMEA Angiotensin II Receptor Sales Price by Type (2027-2032) & (US$/unit) Table 179. SAMEA Angiotensin II Receptor Revenue by Application (2021-2026) & (US$ Million) Table 180. SAMEA Angiotensin II Receptor Revenue by Application (2027-2032) & (US$ Million) Table 181. SAMEA Angiotensin II Receptor Sales by Application (2021-2026) & (k units) Table 182. SAMEA Angiotensin II Receptor Sales by Application (2027-2032) & (k units) Table 183. SAMEA Angiotensin II Receptor Sales Price by Application (2021-2026) & (US$/unit) Table 184. SAMEA Angiotensin II Receptor Sales Price by Application (2027-2032) & (US$/unit) Table 185. SAMEA Angiotensin II Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. SAMEA Angiotensin II Receptor Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. SAMEA Angiotensin II Receptor Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. SAMEA Angiotensin II Receptor Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 189. SAMEA Angiotensin II Receptor Sales by Country (2021-2026) & (k units) Table 190. SAMEA Angiotensin II Receptor Sales by Country (2027-2032) & (k units) Table 191. SAMEA Angiotensin II Receptor Sales Price by Country (2021-2026) & (US$/unit) Table 192. SAMEA Angiotensin II Receptor Sales Price by Country (2027-2032) & (US$/unit) Table 193. Brazil Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 194. Argentina Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 195. Chile Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 196. Colombia Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 197. Peru Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 198. Saudi Arabia Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 199. Israel Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 200. UAE Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 201. Turkey Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 202. Iran Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 203. Egypt Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Table 204. Key Raw Materials Table 205. Raw Materials Key Suppliers Table 206. Angiotensin II Receptor Distributors List Table 207. Angiotensin II Receptor Customers List Table 208. Research Programs/Design for This Report Table 209. Authors List of This Report Table 210. Secondary Sources Table 211. Primary Sources List of Figures Figure 1. Angiotensin II Receptor Image Figure 2. Global Angiotensin II Receptor Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Angiotensin II Receptor Market Size Share 2021 VS 2025 VS 2032 Figure 4. MOR-107 Image Figure 5. KDT-501 Image Figure 6. EMA-401 Image Figure 7. C-21 Image Figure 8. Others Image Figure 9. Global Angiotensin II Receptor Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Angiotensin II Receptor Market Size Share 2021 VS 2025 VS 2032 Figure 11. Women's Health Image Figure 12. Immunology Image Figure 13. Acute Ischemic Stroke Image Figure 14. Respiratory Image Figure 15. Others Image Figure 16. Global Angiotensin II Receptor Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Angiotensin II Receptor Revenue (2021-2032) & (US$ Million) Figure 18. Global Angiotensin II Receptor Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Angiotensin II Receptor Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Angiotensin II Receptor Revenue Market Share by Region (2021-2032) Figure 21. Global Angiotensin II Receptor Sales (2021-2032) & (k units) Figure 22. Global Angiotensin II Receptor Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 23. Global Angiotensin II Receptor Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Angiotensin II Receptor Sales YoY (2021-2032) & (k units) Figure 25. Europe Angiotensin II Receptor Sales YoY (2021-2032) & (k units) Figure 26. China Angiotensin II Receptor Sales YoY (2021-2032) & (k units) Figure 27. Asia (Excluding China) Angiotensin II Receptor Sales YoY (2021-2032) & (k units) Figure 28. South America, Middle East and Africa Angiotensin II Receptor Sales YoY (2021-2032) & (k units) Figure 29. Global Angiotensin II Receptor Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Angiotensin II Receptor Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Angiotensin II Receptor Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Angiotensin II Receptor Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Angiotensin II Receptor Revenue Market Share by Type (2021-2032) Figure 35. Global Angiotensin II Receptor Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Angiotensin II Receptor Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Angiotensin II Receptor Sales Market Share by Type (2021-2032) Figure 38. Global Angiotensin II Receptor Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Angiotensin II Receptor Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Angiotensin II Receptor Revenue Market Share by Application (2021-2032) Figure 41. Global Angiotensin II Receptor Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 42. Global Angiotensin II Receptor Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Angiotensin II Receptor Sales Market Share by Application (2021-2032) Figure 44. North America Angiotensin II Receptor Revenue Share by Type (2021-2032) Figure 45. North America Angiotensin II Receptor Sales Share by Type (2021-2032) Figure 46. North America Angiotensin II Receptor Revenue Share by Application (2021-2032) Figure 47. North America Angiotensin II Receptor Sales Share by Application (2021-2032) Figure 48. North America Angiotensin II Receptor Revenue Share by Country (2021-2032) Figure 49. North America Angiotensin II Receptor Sales Share by Country (2021-2032) Figure 50. Europe Angiotensin II Receptor Revenue Share by Type (2021-2032) Figure 51. Europe Angiotensin II Receptor Sales Share by Type (2021-2032) Figure 52. Europe Angiotensin II Receptor Revenue Share by Application (2021-2032) Figure 53. Europe Angiotensin II Receptor Sales Share by Application (2021-2032) Figure 54. Europe Angiotensin II Receptor Revenue Share by Country (2021-2032) Figure 55. Europe Angiotensin II Receptor Sales Share by Country (2021-2032) Figure 56. China Angiotensin II Receptor Revenue Share by Type (2021-2032) Figure 57. China Angiotensin II Receptor Sales Share by Type (2021-2032) Figure 58. China Angiotensin II Receptor Revenue Share by Application (2021-2032) Figure 59. China Angiotensin II Receptor Sales Share by Application (2021-2032) Figure 60. Asia Angiotensin II Receptor Revenue Share by Type (2021-2032) Figure 61. Asia Angiotensin II Receptor Sales Share by Type (2021-2032) Figure 62. Asia Angiotensin II Receptor Revenue Share by Application (2021-2032) Figure 63. Asia Angiotensin II Receptor Sales Share by Application (2021-2032) Figure 64. Asia Angiotensin II Receptor Revenue Share by Country (2021-2032) Figure 65. Asia Angiotensin II Receptor Sales Share by Country (2021-2032) Figure 66. SAMEA Angiotensin II Receptor Revenue Share by Type (2021-2032) Figure 67. SAMEA Angiotensin II Receptor Sales Share by Type (2021-2032) Figure 68. SAMEA Angiotensin II Receptor Revenue Share by Application (2021-2032) Figure 69. SAMEA Angiotensin II Receptor Sales Share by Application (2021-2032) Figure 70. SAMEA Angiotensin II Receptor Revenue Share by Country (2021-2032) Figure 71. SAMEA Angiotensin II Receptor Sales Share by Country (2021-2032) Figure 72. Angiotensin II Receptor Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Angiotensin II Receptor Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • MOR-107
  • KDT-501
  • EMA-401
  • C-21
  • Others
Applications
  • Women's Health
  • Immunology
  • Acute Ischemic Stroke
  • Respiratory
  • Others
Companies covered
  • CJ HealthCare Corp
  • MorphoSys AG
  • Vicore Pharma AB
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Angiotensin II Receptor Market by Type
  3. 1.2.1 Global Angiotensin II Receptor Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 MOR-107
  5. 1.2.3 KDT-501
  6. 1.2.4 EMA-401
  7. 1.2.5 C-21
  8. 1.2.6 Others
  9. 1.3 Angiotensin II Receptor Market by Application
  10. 1.3.1 Global Angiotensin II Receptor Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Women's Health
  12. 1.3.3 Immunology
  13. 1.3.4 Acute Ischemic Stroke
  14. 1.3.5 Respiratory
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Angiotensin II Receptor Market Dynamics
  1. 2.1 Angiotensin II Receptor Industry Trends
  2. 2.2 Angiotensin II Receptor Industry Drivers
  3. 2.3 Angiotensin II Receptor Industry Opportunities and Challenges
  4. 2.4 Angiotensin II Receptor Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Angiotensin II Receptor Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Angiotensin II Receptor Revenue by Region
  3. 3.2.1 Global Angiotensin II Receptor Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Angiotensin II Receptor Revenue by Region (2021-2026)
  5. 3.2.3 Global Angiotensin II Receptor Revenue by Region (2027-2032)
  6. 3.2.4 Global Angiotensin II Receptor Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Angiotensin II Receptor Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Angiotensin II Receptor Sales by Region
  9. 3.4.1 Global Angiotensin II Receptor Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Angiotensin II Receptor Sales by Region (2021-2026)
  11. 3.4.3 Global Angiotensin II Receptor Sales by Region (2027-2032)
  12. 3.4.4 Global Angiotensin II Receptor Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Angiotensin II Receptor Revenue by Manufacturers
  2. 4.1.1 Global Angiotensin II Receptor Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Angiotensin II Receptor Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Angiotensin II Receptor Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Angiotensin II Receptor Sales by Manufacturers
  6. 4.2.1 Global Angiotensin II Receptor Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Angiotensin II Receptor Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Angiotensin II Receptor Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Angiotensin II Receptor Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Angiotensin II Receptor Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Angiotensin II Receptor Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Angiotensin II Receptor Manufacturers, Product Type & Application
  13. 4.7 Global Angiotensin II Receptor Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Angiotensin II Receptor Market CR5 and HHI
  16. 4.8.2 2025 Angiotensin II Receptor Tier 1, Tier 2, and Tier 3
5 Angiotensin II Receptor Market by Type
  1. 5.1 Global Angiotensin II Receptor Revenue by Type
  2. 5.1.1 Global Angiotensin II Receptor Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Angiotensin II Receptor Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Angiotensin II Receptor Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Angiotensin II Receptor Sales by Type
  6. 5.2.1 Global Angiotensin II Receptor Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Angiotensin II Receptor Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Angiotensin II Receptor Sales Market Share by Type (2021-2032)
  9. 5.3 Global Angiotensin II Receptor Price by Type
6 Angiotensin II Receptor Market by Application
  1. 6.1 Global Angiotensin II Receptor Revenue by Application
  2. 6.1.1 Global Angiotensin II Receptor Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Angiotensin II Receptor Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Angiotensin II Receptor Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Angiotensin II Receptor Sales by Application
  6. 6.2.1 Global Angiotensin II Receptor Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Angiotensin II Receptor Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Angiotensin II Receptor Sales Market Share by Application (2021-2032)
  9. 6.3 Global Angiotensin II Receptor Price by Application
7 Company Profiles
  1. 7.1 CJ HealthCare Corp
  2. 7.1.1 CJ HealthCare Corp Company Information
  3. 7.1.2 CJ HealthCare Corp Business Overview
  4. 7.1.3 CJ HealthCare Corp Angiotensin II Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CJ HealthCare Corp Angiotensin II Receptor Product Portfolio
  6. 7.1.5 CJ HealthCare Corp Recent Developments
  7. 7.2 MorphoSys AG
  8. 7.2.1 MorphoSys AG Company Information
  9. 7.2.2 MorphoSys AG Business Overview
  10. 7.2.3 MorphoSys AG Angiotensin II Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 MorphoSys AG Angiotensin II Receptor Product Portfolio
  12. 7.2.5 MorphoSys AG Recent Developments
  13. 7.3 Vicore Pharma AB
  14. 7.3.1 Vicore Pharma AB Company Information
  15. 7.3.2 Vicore Pharma AB Business Overview
  16. 7.3.3 Vicore Pharma AB Angiotensin II Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Vicore Pharma AB Angiotensin II Receptor Product Portfolio
  18. 7.3.5 Vicore Pharma AB Recent Developments
  19. 7.4 Novartis AG
  20. 7.4.1 Novartis AG Company Information
  21. 7.4.2 Novartis AG Business Overview
  22. 7.4.3 Novartis AG Angiotensin II Receptor Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novartis AG Angiotensin II Receptor Product Portfolio
  24. 7.4.5 Novartis AG Recent Developments
8 North America
  1. 8.1 North America Angiotensin II Receptor Market Size by Type
  2. 8.1.1 North America Angiotensin II Receptor Revenue by Type (2021-2032)
  3. 8.1.2 North America Angiotensin II Receptor Sales by Type (2021-2032)
  4. 8.1.3 North America Angiotensin II Receptor Price by Type (2021-2032)
  5. 8.2 North America Angiotensin II Receptor Market Size by Application
  6. 8.2.1 North America Angiotensin II Receptor Revenue by Application (2021-2032)
  7. 8.2.2 North America Angiotensin II Receptor Sales by Application (2021-2032)
  8. 8.2.3 North America Angiotensin II Receptor Price by Application (2021-2032)
  9. 8.3 North America Angiotensin II Receptor Market Size by Country
  10. 8.3.1 North America Angiotensin II Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Angiotensin II Receptor Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Angiotensin II Receptor Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Angiotensin II Receptor Market Size by Type
  2. 9.1.1 Europe Angiotensin II Receptor Revenue by Type (2021-2032)
  3. 9.1.2 Europe Angiotensin II Receptor Sales by Type (2021-2032)
  4. 9.1.3 Europe Angiotensin II Receptor Price by Type (2021-2032)
  5. 9.2 Europe Angiotensin II Receptor Market Size by Application
  6. 9.2.1 Europe Angiotensin II Receptor Revenue by Application (2021-2032)
  7. 9.2.2 Europe Angiotensin II Receptor Sales by Application (2021-2032)
  8. 9.2.3 Europe Angiotensin II Receptor Price by Application (2021-2032)
  9. 9.3 Europe Angiotensin II Receptor Market Size by Country
  10. 9.3.1 Europe Angiotensin II Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Angiotensin II Receptor Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Angiotensin II Receptor Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Angiotensin II Receptor Market Size by Type
  2. 10.1.1 China Angiotensin II Receptor Revenue by Type (2021-2032)
  3. 10.1.2 China Angiotensin II Receptor Sales by Type (2021-2032)
  4. 10.1.3 China Angiotensin II Receptor Price by Type (2021-2032)
  5. 10.2 China Angiotensin II Receptor Market Size by Application
  6. 10.2.1 China Angiotensin II Receptor Revenue by Application (2021-2032)
  7. 10.2.2 China Angiotensin II Receptor Sales by Application (2021-2032)
  8. 10.2.3 China Angiotensin II Receptor Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Angiotensin II Receptor Market Size by Type
  2. 11.1.1 Asia Angiotensin II Receptor Revenue by Type (2021-2032)
  3. 11.1.2 Asia Angiotensin II Receptor Sales by Type (2021-2032)
  4. 11.1.3 Asia Angiotensin II Receptor Price by Type (2021-2032)
  5. 11.2 Asia Angiotensin II Receptor Market Size by Application
  6. 11.2.1 Asia Angiotensin II Receptor Revenue by Application (2021-2032)
  7. 11.2.2 Asia Angiotensin II Receptor Sales by Application (2021-2032)
  8. 11.2.3 Asia Angiotensin II Receptor Price by Application (2021-2032)
  9. 11.3 Asia Angiotensin II Receptor Market Size by Country
  10. 11.3.1 Asia Angiotensin II Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Angiotensin II Receptor Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Angiotensin II Receptor Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Angiotensin II Receptor Market Size by Type
  2. 12.1.1 SAMEA Angiotensin II Receptor Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Angiotensin II Receptor Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Angiotensin II Receptor Price by Type (2021-2032)
  5. 12.2 SAMEA Angiotensin II Receptor Market Size by Application
  6. 12.2.1 SAMEA Angiotensin II Receptor Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Angiotensin II Receptor Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Angiotensin II Receptor Price by Application (2021-2032)
  9. 12.3 SAMEA Angiotensin II Receptor Market Size by Country
  10. 12.3.1 SAMEA Angiotensin II Receptor Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Angiotensin II Receptor Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Angiotensin II Receptor Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Angiotensin II Receptor Value Chain Analysis
  2. 13.1.1 Angiotensin II Receptor Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Angiotensin II Receptor Production Mode & Process
  6. 13.2 Angiotensin II Receptor Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Angiotensin II Receptor Distributors
  9. 13.2.3 Angiotensin II Receptor Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.